# Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

> **NCT04082975** · PHASE3 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 421 (actual)

## Conditions studied

- Acute Low Back Pain

## Interventions

- **DRUG:** NVP-1203
- **DRUG:** NVP-1203-R
- **DRUG:** NVP-1203 placebo
- **DRUG:** NVP-1203-R placebo

## Key facts

- **NCT ID:** NCT04082975
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-15
- **Primary completion:** 2021-05-24
- **Final completion:** 2021-05-31
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2021-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082975, "Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04082975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*